85 related articles for article (PubMed ID: 31695339)
1. De-Intensification Of Blood Glucose Lowering Medication In People Identified As Being Over-Treated: A Mixed Methods Study.
Hart HE; Ditzel K; Rutten GE; de Groot E; Seidu S; Khunti K; Vos RC
Patient Prefer Adherence; 2019; 13():1775-1783. PubMed ID: 31695339
[TBL] [Abstract][Full Text] [Related]
2. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.
Balkau B; Halimi S; Blickle JF; Vergès B; Avignon A; Attali C; Chartier I; Amelineau E
Ann Endocrinol (Paris); 2016 Dec; 77(6):649-657. PubMed ID: 27646493
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA.
Rattelman CR; Ciemins EL; Stempniewicz N; Mocarski M; Ganguly R; Cuddeback JK
Diabetes Ther; 2021 Feb; 12(2):581-594. PubMed ID: 33460018
[TBL] [Abstract][Full Text] [Related]
4. Assessment and prevention of hypoglycaemia in primary care among U.S. Veterans: a mixed methods study.
Pilla SJ; Meza KA; Beach MC; Long JA; Gordon HS; Bates JT; Washington DL; Bokhour BG; Tuepker A; Saha S; Maruthur NM
Lancet Reg Health Am; 2023 Dec; 28():100641. PubMed ID: 38076413
[TBL] [Abstract][Full Text] [Related]
5. When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
Heisler M; Hogan MM; Hofer TP; Schmittdiel JA; Pladevall M; Kerr EA
Circulation; 2008 Jun; 117(22):2884-92. PubMed ID: 18506011
[TBL] [Abstract][Full Text] [Related]
6. Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes.
Christiaens A; Boland B; Germanidis M; Dalleur O; Henrard S
BMC Geriatr; 2020 Sep; 20(1):367. PubMed ID: 32972389
[TBL] [Abstract][Full Text] [Related]
7. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK
PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127
[TBL] [Abstract][Full Text] [Related]
8. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
9. Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study.
Müller N; Khunti K; Kuss O; Lindblad U; Nolan JJ; Rutten GE; Trento M; Porta M; Roth J; Charpentier G; Jörgens V; Müller UA
Acta Diabetol; 2017 Feb; 54(2):209-214. PubMed ID: 27837286
[TBL] [Abstract][Full Text] [Related]
10. Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes.
LeBlanc ES; Rosales AG; Kachroo S; Mukherjee J; Funk KL; Schneider JL; Nichols GA
BMJ Open Diabetes Res Care; 2015; 3(1):e000062. PubMed ID: 25741443
[TBL] [Abstract][Full Text] [Related]
11. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
12. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
13. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
Malek R; Ajili F; Assaad-Khalil SH; Shinde A; Chen JW; Van den Berg E
Diabetes Metab; 2015 Jun; 41(3):223-30. PubMed ID: 25483023
[TBL] [Abstract][Full Text] [Related]
14. Clinical Predictors of the Need for Further Treatment Escalation in Patients with Type 2 Diabetes on Basal Insulin Therapy - A Retrospective Observational Study.
Buchholz C; Kahle-Stephan M; Meier JJ; Nauck MA
Exp Clin Endocrinol Diabetes; 2019 Oct; 127(10):663-671. PubMed ID: 31412375
[TBL] [Abstract][Full Text] [Related]
15. Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study.
Duru OK; Bilik D; McEwen LN; Brown AF; Karter AJ; Curb JD; Marrero DG; Lu SE; Rodriguez M; Mangione CM
J Gen Intern Med; 2011 May; 26(5):505-11. PubMed ID: 21174165
[TBL] [Abstract][Full Text] [Related]
16. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
17. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
Sonmez A; Tasci I; Demirci I; Haymana C; Barcin C; Aydin H; Cetinkalp S; Ozturk FY; Gul K; Sabuncu T; Satman I; Bayram F;
Diabetes Ther; 2020 May; 11(5):1045-1059. PubMed ID: 32088879
[TBL] [Abstract][Full Text] [Related]
18. Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK.
Valentine WJ; Curtis BH; Pollock RF; Van Brunt K; Paczkowski R; Brändle M; Boye KS; Kendall DM
Diabetes Res Clin Pract; 2015 Jul; 109(1):95-103. PubMed ID: 25989713
[TBL] [Abstract][Full Text] [Related]
19. Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study.
Bellido D; Abellán P; Ruiz Palomar JM; Álvarez Sintes R; Nubiolae A; Bellido V; Romero G;
Curr Ther Res Clin Exp; 2018; 89():37-42. PubMed ID: 30455779
[TBL] [Abstract][Full Text] [Related]
20. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
Schiel R; Ulbrich S; Müller UA
Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
